|
Volumn 33, Issue 2, 1999, Pages 565-568
|
Orphan drugs: The United States experience
|
Author keywords
Food and Drug Administration; Orphan Drug Act; Orphan drugs; Rare diseases
|
Indexed keywords
ORPHAN DRUG;
DRUG DEVELOPMENT;
DRUG INDUSTRY;
DRUG LEGISLATION;
DRUG MANUFACTURE;
DRUG MARKETING;
PRIORITY JOURNAL;
REVIEW;
TAX;
UNITED STATES;
|
EID: 0032995950
PISSN: 00928615
EISSN: None
Source Type: Journal
DOI: 10.1177/009286159903300226 Document Type: Review |
Times cited : (6)
|
References (0)
|